Related Experiment Videos
Assessment of action of cis-diamminodichloro-platinum II on HeLa cells by different methods detects time-dependence
British Journal of Cancer
|December 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer.
Cancer chemotherapy and pharmacology·1991
Onco-developmental protein concentrations in the sera of patients with ovarian cancer prior to treatment.
European journal of cancer & clinical oncology·1988
Drug sensitivity of non small cell carcinoma of lung by clonogenic assay in several media.
British journal of cancer·1986
Lack of comparability between CEA analyses using three different methods.
Annals of clinical biochemistry·1985
Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol.
American journal of obstetrics and gynecology·1984
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026